FDA Clearance to Gamida Cell for GDA-201 Treatment of Follicular & Diffuse Large B Cell Lymphomas
Gamida Cell Ltd. (Nasdaq: GMDA), the leader in nicotinamide (NAM) -enabled cell therapies for patients with hematologic and solid cancers, has received the green light from the U.S. Food and…
Continue Reading
FDA Clearance to Gamida Cell for GDA-201 Treatment of Follicular & Diffuse Large B Cell Lymphomas